Skip to content

Public FDA record

Z-2049-2016: PrismaSate BGK2/0 Dialysis Solution for Continuous Renal Replacement Therapy

Recall record Z-2049-2016 for Baxter Healthcare Corp.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2049-2016
Company in FDA record
Baxter Healthcare Corp.
FDA classification date
Jun 24, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Presence of leaks near top of the PrismaSate bags

Source facts

Action
Baxter Healthcare Corporation sent an Urgent Product Recall communication to affected customers via U.S.P.S. first class mail on 05/23/2016.
Initiated
2016-05-23
Root cause
Other
Terminated
2017-03-28
Distribution
Distributed to Columbia and the following US states: AZ, CA, CO, DE, FL, GA, IA, ID, IL, IN, KY, MA, MD, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OR, PA, TN, TX, UT, VA, WA, WI
Recall number
Z-2049-2016
Recall status
Terminated
CDRH record ID
146917
FDA classified
2016-06-24
Recall event number
74226

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗